Back
Speaker illustration

Ms Hua Shen

Beijing Anzhen Hospital, Beijing (China)

Member of:

European Society of Cardiology

Presentations

The efficacy of tafolecimab in lipoprotein(a) reductions in hypercholesterolaemic patients: a pooled analysis of three phase 3 trials

Event: ESC Congress 2025

Topic: Lipid-Lowering Agents

Session: Dyslipidaemias: current strategies and innovations

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources